膀胱MRI的VI-RADS及其延伸:质控、疗效评估与人工智能
本文为叙述性综述,围绕膀胱癌MRI的VI-RADS标准化分期,阐述从单纯诊断准确性向临床落地与效用的转变。重点讨论图像质量控制、观察者间一致性、经新辅助治疗后的疗效评估体系如nacVI-RADS、定量生物标志物及机器学习方法。文章还展望了人工智能在扫描加速、自动质控、半自动分割和模棱两可病灶判读支持方面的近期应用价值。
要点
- VI-RADS联合T2WI、DWI/ADC和DCE-MRI可标准化区分非肌层浸润性与肌层浸润性膀胱癌。
- 报告时应关注图像质量是否达质控标准,技术不充分与生物学模棱两可需分别对待。
- 新辅助治疗后可采用nacVI-RADS等治疗后评分系统进行疗效评估,不应沿用治疗前标准简单套用。
核心结论
- 膀胱MRI的核心挑战已从诊断准确性转向临床实施与效用,包括图像质控、一致性及临床路径转化。
- 人工智能近期最可能用于扫描加速、自动质控审计、半自动分割及模棱两可病灶的阅片支持。
研究设计与样本
- 本文为叙述性综述,未报告系统检索策略、纳入排除标准或样本量。
- 内容综合了膀胱MRI的采集与判读要点、诊断效能、常见陷阱及VI-RADS实施的规模化解决方案。
诊断标准与关键数值
- VI-RADS通过整合T2WI、DWI伴ADC图及DCE-MRI对膀胱癌进行标准化局部分期。
- 肿瘤一旦侵犯固有肌层,膀胱癌治疗策略发生显著改变,可靠区分NMIBC与MIBC是关键决策点。
临床应用与阅片要点
- VI-RADS质量评分及质控概念有助于区分技术不充分检查与生物学模棱两可病例,报告时应记录图像是否达标。
- 应关注不同扫描设备和流程间图像质量的一致性,以减少观察者间判读变异。
- 将VI-RADS分类转化为临床路径时,不应仅关注分类本身,还需结合图像质量和病灶判读信心。
局限性
- 原文未报告系统检索策略、纳入文献筛选方法或证据质量分级,作为叙述性综述存在选择性引用的可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Management of bladder cancer changes markedly once a tumor invades the muscularis propria, making reliable separation of non-muscle-invasive bladder cancer (NMIBC) from muscle-invasive bladder cancer (MIBC) a key clinical decision point. Multiparametric MRI (mpMRI), interpreted with the Vesical Imaging-Reporting and Data System (VI-RADS), standardizes local staging by integrating T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) maps, and dynamic contrast-enhanced MRI (DCE-MRI). As evidence has matured, the central challenge has shifted from diagnostic accuracy alone to implementation and clinical utility: ensuring interpretable image quality across scanners and workflows, reducing inter-reader variability, and translating VI-RADS categories into appropriate clinical pathways. Bladder MRI is also being evaluated for treatment response assessment after neoadjuvant systemic therapy and bladder-preserving approaches, supported by emerging post-therapy scoring systems such as nacVI-RADS, quantitative biomarkers, and machine-learning methods. The VI-RADS Quality Score and related quality-control concepts may help separate technically inadequate examinations from biologically equivocal cases. Near-term artificial intelligence applications are likely to be most useful for scan acceleration, automated quality auditing, semi-automated segmentation, and reader support for equivocal lesions. This narrative review synthesizes acquisition and interpretation essentials, diagnostic performance, recurrent pitfalls, and scalable solutions for VI-RADS implementation, response assessment, radiomics, and artificial intelligence.
引用
- Aslan, Eryuruk, Park, et al. VI-RADS and beyond in bladder MRI: a pictorial review of quality control, response assessment, and artificial intelligence. Eur J Radiol. 2026. PMID: 42526369. doi:10.1016/j.ejrad.2026.113114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。